Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into ...

After a disappointing phase 1 showing, Janux Therapeutics is kicking one of its bispecific T-cell engagers (TCEs) ...

Its lead T-Cell Engager HCW11-018b is shown to penetrate into the tumor microenvironment with potent and antigen-specific ...

Scientists have uncovered an unexpected way cells can generate cancer-driving proteins—by cutting RNA into shorter, ...

Dendritic cell sarcomas, encompassing a spectrum of neoplasms derived from accessory immune system cells, represent a rare and diagnostically challenging entity. Among these, follicular dendritic cell ...

Researchers at Baylor College of Medicine and collaborating institutions developed a method that reveals the cellular makeup ...

One of the biggest challenges in cancer research is understanding why some tumor cells become especially aggressive, invasive ...

A new UCLA Health Jonsson Comprehensive Cancer Center study suggests that the way immune cells are organized inside melanoma ...

Sapient, a leader in multi-omics data generation for biomarker discovery and clinical insight delivery, has announced the launch of its Tumor Protein Mapping Platform as a suite of mass ...

The epidemiology of tumor lysis syndrome is evolving with the introduction of newer therapies. The occurrence of tumor lysis syndrome has become a less predictable but increasingly important aspect of ...

Researchers at VIB and VUB have developed a powerful new way to study how the immune system behaves inside lung tumors. By ...